This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignee: Abbott Laboratories Corporation. Active years: 1997-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-2001
Title: **David Fletcher Smith: Innovator in Transgenic Mammal Research**
Introduction
David Fletcher Smith, an esteemed inventor based in Athens, GA, has made significant strides in the field of biotechnology. With a total of five patents to his name, his work primarily focuses on the innovative production of humanized milk through transgenic non-human mammals.
Latest Patents
David’s latest patents highlight groundbreaking methodologies and applications involving transgenic mammals. One of his notable inventions is the production of transgenic non-human mammals that express heterologous glycosyltransferase DNA sequences, enabling them to produce oligosaccharides and glycoproteins in their milk. This invention encompasses methods for creating these mammals, as well as compositions derived from their milk, including purified oligosaccharides and glyconjugates.
Another noteworthy patent involves the creation of humanized milk produced by non-human transgenic mammals with a genome containing at least one heterologous gene that encodes a human catalytic entity. Here, specifically, the invention details the production of 2'-fucosyl-lactose in the milk of transgenic mice. This development is vital for the preparation of enteral nutritional products essential for the nutritive maintenance of animals.
Career Highlights
David Fletcher Smith is currently associated with Abbott Laboratories Corporation, a leading company known for its contributions to health products and biotechnology. His expertise and innovative spirit have solidified his status as a prominent inventor in his field.
Collaborations
Throughout his career, David has worked alongside esteemed colleagues such as Pedro A Prieto and John J Kopchick. These collaborations have undoubtedly enriched his research and contributed to successful innovations in transgenic technology.
Conclusion
David Fletcher Smith exemplifies the role of an innovator dedicated to advancing biotechnological research. With his cutting-edge patents and collaborative efforts, he continues to pave the way for new scientific advancements, especially in the production of humanized milk that holds immense potential in nutritional applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile